The present disclosure includes the use of a miRNA inhibitor for treating a symptom or condition of Huntington's disease. The miRNA inhibitor useful for the present disclosure can inhibit miR-485 expression and/or activity, which in turn can modulate the level of proteins or gene expression related to Huntington's disease.
本公开涉及使用miRNA
抑制剂来治疗亨廷顿病的症状或状况。本公开所述的miRNA
抑制剂可以抑制miR-485的表达和/或活性,从而可以调节与亨廷顿病相关的蛋白质或
基因表达
水平。